BEST UNLIMITED TURBO SHORT CERTIFICATE - PFIZER INC | Market Closed - Euronext Paris 17:08:59 15/05/2024 BST | ||
| 0.0135 EUR | -84.12% |
|
| Current month | -92.96% | ||
| 1 month | -92.31% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 15/05/24 | 0.0135 | -84.12% |
| 14/05/24 | 0.085 | +13.33% |
| 13/05/24 | 0.075 | -28.57% |
| 10/05/24 | 0.105 | -8.70% |
| 09/05/24 | 0.115 | 0.00% |
Real-time Euronext Paris
Last update May 15, 2024 at 05:08 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | 
Société Générale
|
| 7K59S | |
| ISIN | DE000SU7RHM2 |
| Date issued | 01/02/2024 |
| Strike | 28.93 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.22 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.395 € |
|---|---|
| Lowest since issue | 0.0135 € |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.38
USD
Average target price
31.94
USD
Spread / Average Target
+12.54%
- Stock Market
- Certificates
- 7K59S Certificat
